MONTPELLIER, France, Nov. 30, 2015 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, is proud to announce the sale of its first ROSA™ robot in the United Kingdom at London's Harley Street Clinic.

London's internationally renowned Harley Street Clinic is a private establishment famed for oncology, cardiology and neuroscience. The neurosurgery department offers high-level medical care through a team of experts equipped with the latest medical equipment. The pediatric department is the largest private unit of its kind in the United Kingdom.

Bertin Nahum, CEO and Founder of Medtech said: "It is with great satisfaction that we can announce this first sale in the United Kingdom and continue our development within Europe. The launch of ROSA™'s first robotic program in the United Kingdom is an important first step in the distribution and adoption of our technology on this market."

About MEDTECH

Founded in 2002 by Bertin NAHUM and based in Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.

In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.

In 2013, MEDTECH received the "European Company of the Year Award" in the "robotic neurosurgery" category from Frost & Sullivan.

In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.

In October 2014, MEDTECH won the "Révélation" prize in the Mediterranean Deloitte Technology Fast 50 Awards.

In 2015, MEDTECH received the "2016 Company of the Year Award" in the " robotic neurosurgery" category from Frost & Sullivan.

CONTACT: CONTACT MEDTECH
         Christophe Sibillin
         Chief Financial Officer
         Tel : +33 (0)4 67 10 77 40

         INVESTORS
         Corinne Puissant
         Tel : +33 (0)1 53 67 36 77
         cpuissant@actus.fr

         PRESS
         Alexandra Prisa (EU)
         Tel. : +33(0)1 53 67 36 90
         aprisa@actus.fr

         Joanna Zimmerman (US)
         Tel : +1 646-536-7006
         jzimmerman@theruthgroup.com

Ads

You May Also Like

Concordia University Ann Arbor announces new Physician Assistant program

Michigan welcomes first Christian-based PA programAnn Arbor, Michigan, Aug. 27, 2018 (GLOBE NEWSWIRE) -- ...

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

DUBLIN, Ireland, April 24, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced ...